-
-
-
Add to Cart The item has been addedO329290-1mgOrfamide A is the major component of a family of cyclic lipopeptides. Orfamide A appears to be a selective antifungal agent. -
Add to Cart The item has been addedO329290-5mgOrfamide A is the major component of a family of cyclic lipopeptides. Orfamide A appears to be a selective antifungal agent. -
Add to Cart The item has been addedO647397-100mgOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
Add to Cart The item has been addedO647397-10mgOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
Add to Cart The item has been addedO647397-2mgOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
Add to Cart The item has been addedO647397-50mgOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
Add to Cart The item has been addedO647397-5mgOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
Add to Cart The item has been addedO655013-1mlOritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae . Oritavancin -
-
